ISPC
Income statement / Annual
Last year (2023), iSpecimen Inc.'s total revenue was $9.93 M,
a decrease of 4.56% from the previous year.
In 2023, iSpecimen Inc.'s net income was -$11.10 M.
See iSpecimen Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$9.93 M
|
$10.40 M
|
$11.14 M
|
$8.18 M
|
$4.30 M
|
$4.39 M
|
Cost of Revenue |
$4.82 M |
$4.76 M |
$5.25 M |
$3.59 M |
$2.13 M |
$2.36 M |
Gross Profit |
$5.11 M |
$5.65 M |
$5.89 M |
$4.60 M |
$2.17 M |
$2.03 M |
Gross Profit Ratio |
0.51 |
0.54 |
0.53 |
0.56 |
0.5 |
0.46 |
Research and Development
Expenses |
$3.57 M
|
$2.66 M
|
$1.84 M
|
$1.43 M
|
$993,329.00
|
$1.21 M
|
General & Administrative
Expenses |
$7.72 M
|
$8.93 M
|
$6.98 M
|
$3.31 M
|
$2.85 M
|
$2.19 M
|
Selling & Marketing
Expenses |
$3.96 M
|
$3.45 M
|
$2.42 M
|
$1.78 M
|
$1.41 M
|
$1.31 M
|
Selling, General &
Administrative Expenses |
$11.68 M
|
$12.37 M
|
$9.40 M
|
$5.08 M
|
$4.26 M
|
$3.51 M
|
Other Expenses |
$1.03 M |
$801,125.00 |
$573,913.00 |
$495,967.00 |
$792,778.00 |
$41,733.00 |
Operating Expenses |
$16.28 M |
$15.83 M |
$11.81 M |
$7.01 M |
$6.05 M |
$5.39 M |
Cost And Expenses |
$21.10 M |
$20.59 M |
$17.06 M |
$10.59 M |
$8.18 M |
$7.75 M |
Interest Income |
$339,750.00 |
$169,345.00 |
$11,397.00 |
$437.00 |
$630.00 |
$1,499.00 |
Interest Expense |
$230,785.00 |
$238,963.00 |
$2.10 M |
$2.10 M |
$1.72 M |
$1.21 M |
Depreciation &
Amortization |
$2.12 M
|
$1.21 M
|
$1.00 M
|
$819,687.00
|
$634,965.00
|
$469,173.00
|
EBITDA |
-$9.10 M
|
-$8.80 M
|
-$5.86 M
|
-$1.74 M
|
-$2.52 M
|
-$3.79 M
|
EBITDA Ratio |
-0.92 |
-0.96 |
-0.54 |
-0.19 |
-0.72 |
-0.65 |
Operating Income Ratio
|
-1.13
|
-0.98
|
-0.53
|
-0.29
|
-0.9
|
-0.76
|
Total Other
Income/Expenses Net |
$69,861.00
|
-$59,840.00
|
-$3.04 M
|
-$2.25 M
|
-$1.00 M
|
-$2.12 M
|
Income Before Tax |
-$11.10 M |
-$10.25 M |
-$8.96 M |
-$4.65 M |
-$4.88 M |
-$5.47 M |
Income Before Tax Ratio
|
-1.12
|
-0.98
|
-0.8
|
-0.57
|
-1.14
|
-1.25
|
Income Tax Expense |
$0.00 |
-$1.21 M |
$1.05 M |
$2.11 M |
-$157,000.00 |
-$127,000.00 |
Net Income |
-$11.10 M |
-$9.04 M |
-$10.02 M |
-$6.76 M |
-$4.73 M |
-$5.35 M |
Net Income Ratio |
-1.12 |
-0.87 |
-0.9 |
-0.83 |
-1.1 |
-1.22 |
EPS |
-1.23 |
-20.47 |
-24.51 |
-144.38 |
-100.99 |
-114.11 |
EPS Diluted |
-24.55 |
-20.44 |
-24.51 |
-144.38 |
-100.99 |
-114.11 |
Weighted Average Shares
Out |
$9.04 M
|
$441,634.00
|
$408,624.00
|
$46,811.00
|
$46,805.00
|
$46,857.00
|
Weighted Average Shares
Out Diluted |
$452,067.00
|
$442,215.00
|
$408,624.00
|
$46,811.00
|
$46,805.00
|
$46,857.00
|
Link |
|
|
|
|
|
|